Results 41 to 50 of about 5,425,254 (156)

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

The Journal of Clinical Investigation
Background Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a rare, autosomal dominant, universally fatal disease without effective treatment options.
Wilson X. Wang, Dan Spiegelman, P. Kumar Rao, Rennie L. Rhee, Andria L. Ford, Jonathan J. Miner, Rajendra S. Apte   +6 more
doaj   +1 more source

Retinopathy of Prematurity: A Clinical Approach

McGill Journal of Medicine, 2020
Retinopathy of prematurity (ROP), previously known as retrolental fibroplasia, was first described by Terry in 1942 (1). It is a vasoproliferative disorder that is a leading cause of childhood blindness in the United States, causing 550 new cases of ...
Andrew Chow, David Weinstock, Alan Berger   +2 more
doaj   +1 more source

Large-scale survey, animal models, and computational modeling identify histological neurodegenerative biomarkers for traumatic optic neuropathy

JCI Insight
BACKGROUND Traumatic optic neuropathy (TON) is a leading cause of blindness following closed traumatic brain injury, with no effective treatments available.
YiKui Zhang, BoYue Xu, ShiWei Huang, ZhaoHui Shi, Wei Xiong, Ruijun Wang, GuiQin Liu, Linlin Chen, ZhenHua Ge, YongJie Zhang, HongLei Liu, BaoYun Jia, ChunXia Wang, HaiHong Shi, Jun Kang, NingYu An, ShuRui Huang, DeFu Chen, ShengHai Huang, YuTing Luo, MingYue Liu, ZhuoWei Wang, ZhongHao Yu, Jingwei Zheng, Wentao Yan, Gen Li, Hao Chen, XingGuang Deng, ShiHui Wei, YunHai Tu, EnDe Wu, Kang Zhang, WenCan Wu   +32 more
doaj   +1 more source

Scientific thinking in ophthalmology

Indian Journal of Ophthalmology, 1998
Science, medicine and ophthalmology have all evolved and progressed through varied but powerful influences over the centuries. While the tremendous technological advances in ophthalmology in the past 20 years are readily appreciated, many clinicians fail
Abraham Chandran
doaj  

Letter to the Editor re: “Effects of the COVID-19 Pandemic on Turkish Ophthalmologists.’’–Incremental Innovations in Clinical Ophthalmology During the COVID-19 Pandemic

Türk Oftalmoloji Dergisi, 2021
Bharat Gurnani, Kirandeep Kaur
doaj   +1 more source

Clinical Utility of Smartphone Applications in Ophthalmology

Ophthalmology Science
Topic: Numerous smartphone applications have been devised for diagnosis, treatment, and symptom management in ophthalmology. Despite the importance of systematic evaluation of the purpose, target disease, effectiveness, and utility of smartphone ...
Ken Nagino, PhD, Jaemyoung Sung, MD, Akie Midorikawa-Inomata, MPH, PhD, Atsuko Eguchi, PhD, Keiichi Fujimoto, MD, PhD, Yuichi Okumura, MD, PhD, Maria Miura, MD, PhD, Alan Yee, PhD, Shokirova Hurramhon, MD, PhD, Kenta Fujio, MD, Yasutsugu Akasaki, MD, Kunihiko Hirosawa, MD, Tianxiang Huang, MD, Mizu Ohno, MD, Yuki Morooka, MD, Xinrong Zou, MD, Hiroyuki Kobayashi, MD, PhD, Takenori Inomata, MD, PhD   +17 more
doaj   +1 more source

Fundamentals and principles of ophthalmology

, 2011
xvi, 455 hal; 20 x 29 ...
American Academy of Ophthalmology
core  

Ophthalmology Program Director Perspectives of Scoring Step 1 Pass/Fail

, 2020
Background Scoring for the United States Medical Licensing Examination (USMLE) Step 1 was recently announced to be reported as binary as early as 2022. The general perception among program directors (PDs) in all specialties has largely been negative, but
Makhoul, Alan T., Law, Janice C., Drolet, Brian C., Lindsey, Jennifer L., Hamdan, Saif A.   +4 more
core   +1 more source

Oculoplastic publication trends in general ophthalmology journals

, 2022
AIM: To examine the publication trend of oculoplastic articles throughout the last decade in general ophthalmology journals. METHODS: A review of all abstracts published between January 2010 to December 2019 in general, clinical ophthalmic journals was ...
Dray, Jean-Paul, Saeed, Peerooz, Gildener-Leapman, Juliana, Zloto, Ofira, Simon, Guy Ben, Souied, Eric, Khatib, Nur   +6 more
core   +1 more source

Hyaluronidase pharmacological properties and clinical application in ophthalmology

Сибирский научный медицинский журнал, 2020
Corneal diseases are the fourth leading cause of blindness in the world, accounting for approximately 5 % of cases. Existing methods of treatment in more than 30 % of cases do not have a full therapeutic effect and when the process is stopped, they end ...
V. E. Zabanova, A. Zh. Fursova, P. G. Madonov   +2 more
doaj   +1 more source